ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Myricetin possesses the potency against SARS-CoV-2 infection through blocking viral-entry facilitators and suppressing inflammation in rats and mice

Pan, Hudan; He, Jinlian; Yang, Zifeng; Yao, Xiaojun; Zhang, Han; Li, Runfeng; Xiao, Yao; Zhao, Caiping; Jiang, Haiming; Liu, Yuntao; Li, Zhanguo; Guo, Bin; Zhang, Chuanhai; Li, Run-Ze*; Liu, Liang*广州医学院; 广州中医药大学; 贵州大学; 北京大学; 1
PHYTOMEDICINE2023-7-25DOI: 10.1016/j.phymed.2023.154858
3被引10阅读
引用收藏
分享

摘要

Background: Myricetin (3,5,7-trihydroxy-2-(3,4,5-tri hydroxyphenyl)-4-benzopyrone) is a common flavonol extracted from many natural plants and Chinese herb medicines and has been demonstrated to have multiple pharmacological activities, such as anti-microbial, anti-thrombotic, neuroprotective, and anti-inflammatory effects. Previously, myricetin was reported to target Mpro and 3CL-Pro-enzymatic activity to SARS-CoV-2. How-ever, the protective value of myricetin on SARS-Cov-2 infection through viral-entry facilitators has not yet been comprehensively understood. @@@ Purpose: The aim of the current study was to evaluate the pharmacological efficacy and the mechanisms of action of myricetin against SARS-CoV-2 infection both in vitro and in vivo. @@@ Methods: The inhibitory effects of myricetin on SARS-CoV-2 infection and replication were assessed on Vero E6 cells. Molecular docking analysis and bilayer interferometry (BLI) assays, immunocytochemistry (ICC), and pseudoviruses assays were performed to evaluate the roles of myricetin in the intermolecular interaction between the receptor binding domain (RBD) of the SARS-CoV-2 spike (S) protein and angiotensin-converting enzyme 2 (ACE2). The anti-inflammatory potency and mechanisms of myricetin were examined in THP1 macrophages in vitro, as well as in carrageenan-induced paw edema, delayed-type hypersensitivity (DTH) induced auricle edema, and LPS-induced acute lung injury (ALI) animal models. @@@ Results: The results showed that myricetin was able to inhibit binding between the RBD of the SARS-CoV-2 S protein and ACE2 through molecular docking analysis and BLI assay, demonstrating its potential as a viral-entry facilitator blocker. Myricetin could also significantly inhibit SASR-CoV-2 infection and replication in Vero E6 cells (EC50 55.18 mu M), which was further validated with pseudoviruses containing the RBD (wild-type, N501Y, N439K, Y453F) and an S1 glycoprotein mutant (S-D614G). Moreover, myricetin exhibited a marked suppressive action on the receptor-interacting serine/threonine protein kinase 1 (RIPK1)-driven inflammation and NF-kappa B signaling in THP1 macrophages. In animal model studies, myricetin notably ameliorated carrageenan-induced paw edema in rats, DTH induced auricle edema in mice, and LPS-induced ALI in mice. @@@ Conclusion: Our findings showed that myricetin inhibited HCoV-229E and SARS-CoV-2 replication in vitro, blocked SARS-CoV-2 virus entry facilitators and relieved inflammation through the RIPK1/NF-cB pathway, suggesting that this flavonol has the potential to be developed as a therapeutic agent against COVID-19.

学科与关键词

关键词
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)MyricetinReceptor Binding Domain (RBD)Angiotensin-converting enzyme 2 (ACE2)Inflammation
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
PHYTOMEDICINE
发表日期
2023-07-25
卷期
第 116 卷
页码
154858
DOI
10.1016/j.phymed.2023.154858
语言
GERMAN
成果收录
SCIE
资助标注
National Key Research and Development Project of China [2020YFA0708003, 2022YFC0867500]; Macao science and technology development fund [0094/2018/A3]

作者

  • P

    Pan, Hudan (第一作者)

    2 · guangzhou univ chinese med

  • H

    He, Jinlian

查看全部 15 位作者收起作者
  • Y

    Yang, Zifeng

    1 · guangzhou med univ

  • Y

    Yao, Xiaojun

  • Z

    Zhang, Han

    tianjin univ tradit chinese med

  • L

    Li, Runfeng

    1 · guangzhou med univ

  • X

    Xiao, Yao

  • Z

    Zhao, Caiping

  • J

    Jiang, Haiming

    1 · guangzhou med univ

  • L

    Liu, Yuntao

    2 · guangzhou univ chinese med

  • L

    Li, Zhanguo

    peking univ

  • G

    Guo, Bin

    guizhou univ

  • Z

    Zhang, Chuanhai

  • L

    Li, Run-Ze (通讯)

    2 · guangzhou univ chinese med

  • L

    Liu, Liang (通讯)

    2 · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417